Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9AUA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,155
Award facts
- Contract value 100% obligated
- $32,154.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,154.53 to AmerisourceBergen Drug Corp for the supply of KESIMPTA 20 mg/0.4 ml pen injectors. The contract, awarded on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and has demonstrated capability to meet competitive procurement requirements through its extensive portfolio of federal contract awards. The company's IDC with DLA encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and the U.S. Coast Guard. KESIMPTA is a specialty pharmaceutical product used in the treatment of multiple sclerosis, reflecting the breadth of therapeutic areas covered under the contractor's federal supply agreements.
Quick answers
Who was awarded contract SPE2DR26F9AUA?
SPE2DR26F9AUA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F9AUA worth?
The government has obligated $32,155 on SPE2DR26F9AUA.
Is contract SPE2DR26F9AUA an order under another contract?
Yes. SPE2DR26F9AUA is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9AUA competed?
The extent of competition for SPE2DR26F9AUA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award